New hope for kids with tough cancers: experimental drug CLR 131 enters human testing
NCT ID NCT03478462
First seen Mar 22, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This early-stage study tests an experimental drug, CLR 131, in 30 children, adolescents, and young adults whose solid tumors, lymphoma, or brain tumors have returned or not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look for signs that the drug shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Duke University
Chapel Hill, North Carolina, 27708, United States
-
Hospital for Sick Children
Toronto, Ontario, M5G1X8, Canada
-
Lucile Packard Children's Hospital
Palo Alto, California, 94304, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
-
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.